Literature DB >> 33435858

NF-κB 1-induced LINC00665 regulates inflammation and apoptosis of neurons caused by spinal cord injury by targeting miR-34a-5p.

Qilong Deng1,2, Lili Ma1,2, Ting Chen1,2, Yu Yang1,2, Yuetao Ma1,2, Lizhong Ma1,2.   

Abstract

Background: Spinal cord injury (SCI) has high disability rate and low cure rate, which frustrates the patients and brings a heavy burden to their families. This study aimed to explore whether NF-κB1 could induce the expression of LINC00665 and form a feedback loop with miR-34a-5p to regulate inflammation and apoptosis of neurons.
Results: Basso, Beattie, and Bresnahan (BBB) scoring was decreased, damage for spinal cord tissue was aggravated and neuron number was decreased in SCI rats. The levels of TNF-α, IL-1β and IL-6 in serum and the expression of LINC00665 and NF-κB1 in spinal cord tissues were all increased in SCI rats. After LPS induction, PC12 cell viability was decreased. The expression of LINC00665 and NF-κB1 in LPS-induced PC12 cells was increased, which was partially reversed by BAY11-7082 (NF-κB inhibitor). Inhibition of LINC00665 improved cell viability, suppressed apoptosis and inflammation and down-regulated the NF-κB1 expression in LPS-induced PC12 cells. Furthermore, miR-34a-5p expression was decreased in LPS-induced PC12 cells, which could be promoted by inhibition of LINC00665. miR-34a-5p inhibitor restrained the effect of inhibition of LINC00665 on NF-κB1 expression in LPS-induced PC12 cells.
Conclusion: inhibition of LINC00665 improved cell viability, suppressed apoptosis and inflammation in LPS-induced PC12 cells, and the NF-κB1/LINC00665/miR-34a-5ploop might be a useful therapeutic target in SCI treatment.

Entities:  

Keywords:  LINC00665; NFKB1; apoptosis; inflammation; miR-34a-5p; spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 33435858     DOI: 10.1080/01616412.2020.1866373

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

1.  MicroRNA-122-3p plays as the target of long non-coding RNA LINC00665 in repressing the progress of arthritis.

Authors:  Zhiyan Wang; Qijun Tian; Yumei Tian; Zhonghua Zheng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.

Authors:  Chenming Zhong; Zijun Xie; Jinze Shen; Yunhua Jia; Shiwei Duan
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

3.  Confirmation of inhibitingTLR4/MyD88/NF-κB Signalling Pathway by Duhuo Jisheng Decoction on Osteoarthritis: A Network Pharmacology Approach-Integrated Experimental Study.

Authors:  Linglong Liu; Limei Xu; Shengjie Wang; Lili Wang; Xiaoning Wang; Huifeng Xu; Xihai Li; Hongzhi Ye
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

4.  NSD1 Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint.

Authors:  Giuseppina Conteduca; Davide Cangelosi; Simona Coco; Michela Malacarne; Chiara Baldo; Alessia Arado; Rute Pinto; Barbara Testa; Domenico A Coviello
Journal:  Life (Basel)       Date:  2022-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.